Cancer 2015: a longitudinal whole-of-system study of genomic cancer medicine.
Genomic cancer medicine promises revolutionary change in oncology. The impacts of 'personalized medicine', based upon a molecular classification of cancer and linked to targeted therapies, will extend from individual patient outcomes to the health economy at large. To address the 'whole-of-system' impact of genomic cancer medicine, we have established a prospective cohort of patients with newly diagnosed cancer in the state of Victoria, Australia, about whom we have collected a broad range of clinical, demographic, molecular, and patient-reported data, as well as data on health resource utilization. Our goal is to create a model for investigating public investment in genomic medicine that maximizes the cost:benefit ratio for the Australian community at large.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
DOI
EISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- Prospective Studies
- Precision Medicine
- Neoplasms
- Medicine
- Medicinal & Biomolecular Chemistry
- Longitudinal Studies
- Humans
- Genomics
- Australia
- 3214 Pharmacology and pharmaceutical sciences
Citation
Published In
DOI
EISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- Prospective Studies
- Precision Medicine
- Neoplasms
- Medicine
- Medicinal & Biomolecular Chemistry
- Longitudinal Studies
- Humans
- Genomics
- Australia
- 3214 Pharmacology and pharmaceutical sciences